In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis

Meiotic sex in Chagas disease parasite Trypanosoma cruzi

(2019) Philipp Schwabl et al.   Nature Communications

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcV

(2019) Susana Revollo et al.   Pathogens

Current Approaches to Drug Discovery for Chagas Disease: Methodological Advances

(2019) Cauê B. Scarim et al.   COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING

Current trends in the pharmacological management of Chagas disease

(2019) Vanessa Ribeiro et al.   International Journal for Parasitology-Drugs and Drug Resistance

Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail

(2018) C. Crespillo-Andújar et al.   CLINICAL MICROBIOLOGY AND INFECTION

Chagas disease

(2018) José A Pérez-Molina et al.   LANCET

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery

(2018) Lorna M. MacLean et al.   PLoS Neglected Tropical Diseases

Whole genome sequencing of Trypanosoma cruzi field isolates reveals extensive genomic variability and complex aneuploidy patterns within TcII DTU

(2018) João Luís Reis-Cunha et al.   BMC GENOMICS

Transcriptome and Functional Genomics Reveal the Participation of Adenine Phosphoribosyltransferase in Trypanosoma cruzi Resistance to Benznidazole

(2017) Paola García-Huertas et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America

(2017) Eloan Pinheiro et al.   Revista da Sociedade Brasileira de Medicina Tropical

Current drug therapy and pharmaceutical challenges for Chagas disease

(2016) José Bermudez et al.   ACTA TROPICA

Over Six Thousand Trypanosoma cruzi Strains Classified into Discrete Typing Units (DTUs): Attempt at an Inventory

(2016) Simone Frédérique Brenière et al.   PLoS Neglected Tropical Diseases

Genetic diversity of Trypanosoma cruzi in bats, and multilocus phylogenetic and phylogeographical analyses supporting Tcbat as an independent DTU (discrete typing unit)

(2015) Luciana Lima et al.   ACTA TROPICA

Between a bug and a hard place:Trypanosoma cruzigenetic diversity and the clinical outcomes of Chagas disease

(2015) Louisa A Messenger et al.   Expert Review of Anti-Infective Therapy

Chagas’ Disease

(2015) Caryn Bern   NEW ENGLAND JOURNAL OF MEDICINE

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

(2015) Xiang Wan et al.   BMC Medical Research Methodology

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert

(2014) Mônica C.O. Campos et al.   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

Finding your way out of the forest without a trail of bread crumbs: development and evaluation of two novel displays of forest plots

(2014) Anne H. E. Schild et al.   Research Synthesis Methods

Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease

(2013) R. Viotti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Global economic burden of Chagas disease: a computational simulation model

(2013) Bruce Y Lee et al.   LANCET INFECTIOUS DISEASES

Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections

(2013) ROB DON et al.   PARASITOLOGY

In vivo imaging of trypanosomes for a better assessment of host–parasite relationships and drug efficacy

(2013) S. Goyard et al.   PARASITOLOGY INTERNATIONAL

P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance

(2013) Mônica Caroline Oliveira Campos et al.   PARASITOLOGY RESEARCH

Putative Panmixia in Restricted Populations of Trypanosoma cruzi Isolated from Wild Triatoma infestans in Bolivia

(2013) Christian Barnabe et al.   PLoS One

First Report of HumanTrypanosoma cruziInfection Attributed to TcBat Genotype

(2013) J. D. Ramírez et al.   Zoonoses and Public Health

Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population

(2012) Ana Maria Mejia et al.   JOURNAL OF INFECTIOUS DISEASES

The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications

(2011) Bianca Zingales et al.   INFECTION GENETICS AND EVOLUTION

Antitrypanosomal Therapy for Chronic Chagas' Disease

(2011) Caryn Bern   NEW ENGLAND JOURNAL OF MEDICINE

Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment

(2010) D. d. G. J. Batista et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chagas disease

(2010) Anis Rassi et al.   LANCET

High-content imaging for automated determination of host-cell infection rate by the intracellular parasite Trypanosoma cruzi

(2010) L.L. Nohara et al.   PARASITOLOGY INTERNATIONAL

Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches

(2009) Julio A. Urbina   ACTA TROPICA

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE